Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.43 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.43 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SRD5A1 | P18405 | 3/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.43 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.42 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.42 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23630698 | 0.89 | CYP17A1 (0.48) | MEN1KMT2ACYP3A4LMNACYP17A1 | |
| SCHEMBL7196987 | 0.89 | CYP17A1 (0.48) | MEN1KMT2ACYP3A4LMNACYP17A1 | |
| SCHEMBL8342869 | 0.89 | CYP17A1 (0.48) | MEN1KMT2ACYP3A4LMNACYP17A1 | |
| SCHEMBL7196993 | 0.89 | CYP17A1 (0.48) | MEN1KMT2ACYP3A4LMNACYP17A1 | |
| SCHEMBL8347257 | 0.89 | CYP17A1 (0.48) | MEN1KMT2ACYP3A4LMNACYP17A1 | |
| SCHEMBL6436575 | 0.89 | CYP3A4 (0.46) | MEN1KMT2ACYP3A4LMNACYP2C9 | |
| SCHEMBL5897208 | 0.89 | CYP3A4 (0.46) | MEN1KMT2ACYP3A4LMNACYP2C9 | |
| SCHEMBL6444134 | 0.87 | MEN1 (0.44) | MEN1KMT2ASRD5A1SRD5A2 | |
| SCHEMBL6442617 | 0.87 | MEN1 (0.44) | MEN1KMT2ACYP3A4LMNACYP2C9 | |
| SCHEMBL11329429 | 0.87 | AR (0.42) | MEN1KMT2ACYP3A4LMNACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050159366-A1 | Pharmaceutical compositions and treatment methods - 8 | BIOVIE INC. | 2005-07-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159366-A1 | Pharmaceutical compositions and treatment methods - 8 | HSD17B7, NR5A1, HSD3B1 | MEN1 2269/4885KMT2A 2320/4885CYP3A4 144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.